Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

WASHINGTON, May 07, 2025--(BUSINESS WIRE)--Nature Medicine today published a study showing that Perspectum’s iron corrected T1, or cT1, predicts liver-related and cardiac outcomes, including ...

A new low-cost, noninvasive test has been developed that can accurately detect liver disease in its early stages. The 'Medex test' is based on neuroreflexology, a branch of complementary medicine ...

Nature Medicine today published a study showing that Perspectum’s iron corrected T1, or cT1, predicts liver-related and cardiac outcomes, including morbidity. Liver disease is a modifiable ...

Nature Medicine today published a study showing that Perspectum's iron corrected T1, or cT1, predicts liver-related and cardiac outcomes, including morbidity. Liver disease is a modifiable cardiac ...